Evaluate the immunogenicity and safety of rabies vaccine given in a post-exposure prophylaxis regimen to healthy children and adults aged 10-60 years.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
630
Administration of PCECV according to ESSEN regimen
Danyang CDC
Danyang, Jiangsu, China
serum bactericidal activity
Time frame: measured at day 14 and day 45 after first vaccination dose
solicited local and systemic reactions
Time frame: within 6 days following vaccination and adverse events thought the study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.